Patrick J. Balthrop, Sr. is the founding principal of Apalachee Ventures. He has over 30 years of experience building, growing and optimizing businesses in the healthcare sector, particularly in the life sciences segments of diagnostics, life science tools and medical devices. Previously, Mr. Balthrop was CEO, President and Director of Luminex Corporation, a publicly-traded diagnostics, tools and devices company. During his ten year tenure as CEO, Luminex increased sales more than eight-fold, transitioned from a loss position to segment-leading levels of profitability, made several strategic acquisitions and introduced numerous new products.
Prior to Luminex, Mr. Balthrop was President of Fisher Healthcare from 2002 to 2004. He also had a 20 year career at Abbott from 1981 to 2002, where he ran the company’s worldwide commercial operation, was the first head of Abbott Vascular, ran several R&D programs and was GM of the Far East Area, among other accomplishments.
In addition to being a director of Personalis, Mr. Balthrop is Chairman of the Board of Oxford Immunotec PLC (NASDAQ: OXFD), Discovery Life Sciences and Agendia NV. He also serves as an executive advisor to the private equity firm Water Street Healthcare Partners.
Mr. Balthrop has an MBA from the Kellogg School of Management at Northwestern University, and a BS in Biology from Spring Hill College.